for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

COMPASS Pathways PLC

CMPS.O

Latest Trade

39.68USD

Change

0.28(+0.71%)

Volume

338,055

Today's Range

38.60

 - 

40.00

52 Week Range

22.51

 - 

61.69

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
39.40
Open
39.99
Volume
338,055
3M AVG Volume
9.39
Today's High
40.00
Today's Low
38.60
52 Week High
61.69
52 Week Low
22.51
Shares Out (MIL)
36.74
Market Cap (MIL)
1,584.44
Forward P/E
--
Dividend (Yield %)
--

Next Event

Compass Pathways PLC at JMP Securities Life Sciences Virtual Conference

Latest Developments

More

Compass Pathways Announces Pricing Of Public Offering

Compass Pathways PLC Files For Offering 4 Million American Depositary Shares - SEC Filing

Compass Pathways Reports Q4 Loss Per Share $0.52

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About COMPASS Pathways PLC

COMPASS Pathways PLC is a mental health care company. The Company is focused on developing treatments for people suffering with mental health challenges. It is initially focused on treatment-resistant depression (TRD). It is developing COMP360, a polymorphic crystalline formulation of psilocybin. Its COMP360 psilocybin therapy comprises administration of its COMP360 with psychological support from specially trained therapists with specific professional and educational qualifications. The psilocybin administration session lasts approximately six to eight hours, with patients supported by therapists in a non-directive manner. The psilocybin administration sessions are preceded by preparation sessions, in which patients are given a thorough orientation, and followed by integration sessions to help patients process the range of emotional and physical experiences facilitated by COMP360. The Company is developing COMP360 in conjunction with psychological support in a Phase-IIb trial.

Industry

Biotechnology & Drugs

Contact Info

3Rd Floor, 1 Ashley Road, Altrincham

WA14 2DT

United Kingdom

+44.1646.9053974

https://compasspathways.com/

Key Stats

1.75 mean rating - 8 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2020

0.0K

2021(E)

0.0K
EPS (USD)

2020

-3.550

2021(E)

-1.457
Price To Earnings (TTM)
--
Price To Sales (TTM)
--
Price To Book (MRQ)
7.73
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up